Influence of Social Media Ads on Food Choice - Master Protocol
Primary and study completion pushed from Jun 2026 to Jun 2027
NYU Langone HealthNot applicable NCT07249398 Registry history of NCT07249398 on ClinicalTrials.gov (opens the registry)
11 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 6 with minor changes only.
Primary and study completion pushed from Jun 2026 to Jun 2027
NYU Langone HealthNot applicable NCT07249398 Registry history of NCT07249398 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Jun 30, 2027
Also in this update: Sponsor changed: Columbia University to NYU Langone Health; Trial sites expanded: 1 → 4 locations
NYU Langone HealthNot applicable NCT05675345 Registry history of NCT05675345 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 31, 2026 to Dec 31, 2027
NYU Langone HealthNot specified NCT05615415 Registry history of NCT05615415 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Dec 2030 to Aug 2032
NYU Langone HealthNot applicable NCT07219199 Registry history of NCT07219199 on ClinicalTrials.gov (opens the registry)
Primary and study completion pushed from Mar 2026 to Mar 2027
NYU Langone HealthNot applicable NCT05815199 Registry history of NCT05815199 on ClinicalTrials.gov (opens the registry)
Enrollment closed, study ongoing
NYU Langone HealthPhase 3 NCT05591118 Registry history of NCT05591118 on ClinicalTrials.gov (opens the registry)
Trial completed
NYU Langone HealthPhase 2 NCT02621151 Registry history of NCT02621151 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of Jan 15, 2026 to Aug 18, 2025
NYU Langone HealthNot applicable NCT05943509 Registry history of NCT05943509 on ClinicalTrials.gov (opens the registry)
Trial completed
Also in this update: Primary completion date changed from estimate of May 2026 to Jun 30, 2026
NYU Langone HealthNot applicable NCT05166785 Registry history of NCT05166785 on ClinicalTrials.gov (opens the registry)
Enrollment increased: 356 → 450 participants
NYU Langone HealthNot applicable NCT06077838 Registry history of NCT06077838 on ClinicalTrials.gov (opens the registry)
Study completion pushed from Aug 31, 2026 to Apr 25, 2027
NYU Langone HealthNot specified NCT03927768 Registry history of NCT03927768 on ClinicalTrials.gov (opens the registry)
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-15 | NCT07874490 Osimertinib and Cyclosporine A to Enhance Antitumor Efficacy in NSCLC | Phase 2 | Recruiting |
| 2026-10-13 | NCT07870434 The Metabolic Response of Unweighted Treadmill Walking | Completed | |
| 2026-10-13 | NCT07870447 Preoperative Celecoxib and Acetaminophen Versus Acetaminophen Alone for Pain Control… | Phase 1/2 | Not Yet Recruiting |
| 2026-10-07 | NCT07862738 Inspiratory Muscle Training in Hospitalized Patients With Heart Failure Awaiting Advanced… | Not Yet Recruiting | |
| 2026-10-02 | NCT07853690 Histotripsy in Biliary Tract Cancer | Not Yet Recruiting | |
| 2026-09-30 | NCT07849413 Visual Hallucinations in Lewy Body Diseases | Recruiting | |
| 2026-09-25 | NCT07841886 XRAIconnect Image Guidance Software for ERCP Procedures | Not Yet Recruiting | |
| 2026-09-24 | NCT07838181 Virtual Reality Aniseikonia and Metamorphopsia Testing | Recruiting |
| Early Phase 1 | 4 | |
| Phase 1 | 13 | |
| Phase 1/2 | 3 | |
| Phase 2 | 29 | |
| Phase 2/3 | 2 | |
| Phase 3 | 7 | |
| Phase 4 | 13 |
Heart Disease (22) · Prostate Cancer (13) · Diabetes (10) · Breast Cancer (9) · Dementia (9) · Depression (9) · Hypertension (7) · Lung Cancer (7) · Type 2 Diabetes (7) · Chronic Kidney Disease (6)